Yamamoto Taketsugu, Oshima Takashi, Yoshihara Kazue, Nishi Teppei, Arai Hiromasa, Inui Kenji, Kaneko Takeshi, Nozawa Akinori, Adachi Hiroyuki, Rino Yasushi, Masuda Munetaka, Imada Toshio
Department of Surgery, Yokohama City University, Yokohama-city, Kanagawa 236-0004;
Exp Ther Med. 2012 May;3(5):797-802. doi: 10.3892/etm.2012.493. Epub 2012 Feb 22.
Insulin-like growth factor-1 receptor (IGF-1R) and matrix metalloproteinase-7 (MMP-7) have been reported to be related to tumor invasion and metastasis in various malignancies. The aim of this study was to evaluate the expression levels of IGF-1R and MMP-7 in resected non-small cell lung cancer (NSCLC) and to examine the relationship of such levels to clinical characteristics and survival. Expression was measured immunohistochemically. The percentage of stained cells was multiplied by the staining intensity. The sample was classified as high when the score was equal or higher than the median value or was otherwise considered to be low. High IGF-1R expression was associated with nodal metastasis and recurrence (P=0.034 and 0.006, respectively). High IGF-1R expression was associated with significantly poorer overall survival than low IGF-1R expression (P=0.011). MMP-7 expression did not significantly correlate with any clinicopathological factor. There was a trend toward slightly, but not significantly poorer survival in patients with MMP-7-high tumors than in those with MMP-7-low tumors (P=0.220). There was no significant correlation between IGF-1R expression and MMP-7 expression (P=0.184). Upon multivariate analysis, IGF-1R expression was independently related to the outcomes of patients with NSCLC. Overexpression of IGF-1R may be a useful predictor of lymph node metastasis, recurrence and post-surgical outcomes in patients with NSCLC.
胰岛素样生长因子-1受体(IGF-1R)和基质金属蛋白酶-7(MMP-7)已被报道与多种恶性肿瘤的肿瘤侵袭和转移有关。本研究的目的是评估IGF-1R和MMP-7在切除的非小细胞肺癌(NSCLC)中的表达水平,并研究这些水平与临床特征和生存的关系。采用免疫组织化学法测定表达情况。将染色细胞的百分比乘以染色强度。当评分等于或高于中位数时,样本被分类为高表达,否则被认为是低表达。高IGF-1R表达与淋巴结转移和复发相关(分别为P = 0.034和0.006)。高IGF-1R表达组的总生存期明显低于低IGF-1R表达组(P = 0.011)。MMP-7表达与任何临床病理因素均无显著相关性。MMP-7高表达肿瘤患者的生存率略低于MMP-7低表达肿瘤患者,但差异无统计学意义(P = 0.220)。IGF-1R表达与MMP-7表达之间无显著相关性(P = 0.184)。多因素分析显示,IGF-1R表达与NSCLC患者的预后独立相关。IGF-1R的过表达可能是NSCLC患者淋巴结转移、复发和术后预后的有用预测指标。